Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

2152-44-5

Betamethasone valerate

2152-44-5
18109-81-4

Butamirate Citrate

18109-81-4
202189-78-4

Bilastine

202189-78-4
21912-49-2

Brombuterol HCl

21912-49-2
53152-21-9

Buprenorphine HCl

53152-21-9
357336-20-0

Brivaracetam

357336-20-0
357336-19-7

(4S)-Brivaracetam

357336-19-7
132-69-4

Benzydamine HCl

132-69-4
846-48-0

Boldenone

846-48-0
66722-44-9

Bisoprolol

66722-44-9
63659-18-7

Betaxolol

63659-18-7
2438-72-4

Bufexamac

2438-72-4
519-09-5

Benzoylecgonine

519-09-5
81732-46-9

Bambuterol Hydrochloride

81732-46-9
151-73-5

Betamethasone 21-Phosphate Disodium Salt

151-73-5
603-50-9

Bisacodyl

603-50-9
157212-55-0

Bosentan Monohydrate

157212-55-0
52485-79-7

Buprenorphine

52485-79-7
51333-22-3

Budesonide

51333-22-3
88426-33-9

Buparvaquone

88426-33-9